A journey to parenthood: shedding light on fertility for Canadian Infertility Awareness Week
MISSISSAUGA, ON, April 22, 2019 /CNW/ - One in six Canadian couples of childbearing age experience fertility challengesi, a number that has doubled since the 1980s.ii April 22 to 27 is Canadian Infertility Awareness Week, and EMD Serono, Canada is bringing attention to the far-reaching impact of infertility to encourage couples to educate themselves on reproductive health and family planning.
Infertility can be defined as a failure to achieve a clinical pregnancy after 12 months of attempted conception without contraception. A fertility consultation may be recommended after one year of attempted conception for women under 35 years of age and 6 months for women over 35 years of age.iii Age, length of time trying to conceive, hormone levels, medical history and other factors can all contribute to fertility.iv
"When my husband and I found out we were going to need help starting our family, we had no idea what to expect," said Breya Rolt, first-time mom from Burlington, Ontario. "No one really talks about fertility issues until you are thrown into it. When we opened up about our experience, we were surprised to learn just how many people were in the same boat."
Fertility challenges are often viewed as an issue affecting the female reproductive system, but men are almost just as likely as women to experience fertility challenges.vi Fertility specialists can make recommendations to help couples conceive naturally or with assisted reproductive technology. But some couples may delay or decline treatments due to the perceived social stigma associated with fertility challenges.
"Making the decision to start a family is usually a pretty private thing and it can feel like you are losing some of that privacy when you have to reach out for help. But what we lost in privacy, we gained in support. We are grateful for the team of doctors and nurses at our fertility clinic who helped us make our dream of starting a family come true," said Rolt.
It is important for couples trying to conceive to educate themselves on their reproductive health and fertility options.
"It is never too early to talk to your family doctor or OB/GYN about fertility," said Dr. Shannon Corbett, Medical Director and Partner, The Reproductive Care Centre. "Learning about your reproductive health is an important part of family planning. Couples trying to conceive are encouraged to have these conversations with their doctor so they can understand their options and make the best decision for themselves and their family at any stage of their fertility journey."
About Infertility An estimated one in six Canadian couples of childbearing age experience fertility challenges.vii Infertility can be defined as a failure to achieve a clinical pregnancy after 12 months of attempted conception without contraception. A fertility consultation may be recommended after one year of attempted conception for women under 35 years of age and 6 months for women over 35 years of age.viii
Fertility challenges can affect both men and women, or a combination of both. Causes of fertility issues in men may include poor sperm quality, low sperm count, a history of sexually transmitted disease and a hormonal imbalance.ix Potential causes for women include age (fertility decreases after age 35), problems producing eggs, a history of sexually transmitted diseases, problems in the uterus or fallopian tubes, endometriosis, hormonal imbalances and early menopause.x
About EMD Serono, Canada EMD Serono, Canada, is the Canadian biopharmaceutical business of Merck KGaA, Darmstadt, Germany. EMD Serono, Canada has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs. EMD Serono, Canada has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in neurology, oncology, immunology and immuno-oncology. Today, EMD Serono, Canada has more than 100 employees across Canada with headquarters in Mississauga, Ontario.
About Merck KGaA, Darmstadt, Germany Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2018, Merck KGaA, Darmstadt, Germany, generated sales of € 14.8 billion in 66 countries.
The company holds the global rights to the name and trademark "Merck" internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company's technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Long-Term Care and Retirement Home Workers Launch Campaign with Direct Message: Tell Them to Care
RICHMOND HILL, ON, April 19, 2019 /CNW/ - SEIU Healthcare, a union that represents over 60,000 frontline healthcare workers in Ontario, has launched a public advocacy campaign calling on Ontario's major long-term care and retirement home corporations to invest more profits in care.
The campaign titled "Tell Them To Care," is appealing to families in Ontario to join with the frontline workers who are calling on large for-profit healthcare corporations including Chartwell, Extendicare, Sienna and Revera to fix the systemic problems that arise as a result of chronic understaffing.
The first television advertisement is set to air Friday, April 19, 2019 during the Toronto Maple Leafs playoff hockey game broadcast on CBC at 7:00 pm EST.
SEIU Healthcare is preparing to bargain with these companies to address the problems that arise from diverting profits away from improving care. Understaffing in long-term care and retirement homes means that staff are overburdened, workplace injuries increase, and isolated seniors don't get the level of care they deserve and require.
"It's long overdue that these greedy long-term care corporations put resident care ahead of profits," said SEIU Healthcare President Sharleen Stewart. "Frontline healthcare workers are telling us that inadequate staffing levels are a big reason for workplace injury, as well as the increasingly difficult pressures of caring for more seniors with less time."
"If these billion-dollar corporations can afford to pay CEOs millions in compensation and investors tens of millions of dollars in dividends, it's time they seriously address the crisis of understaffing."
"Every day I hear stories from our members about how understaffing affects the care they are able to provide. I hear stories of injuries that could have been prevented if there were adequate staffing levels. I hear about residents going to dinner in their pajamas because there wasn't enough staff to change them earlier. This is about safety, dignity, and the kind of quality care seniors should expect to receive," added Stewart.
SEIU Healthcare represents more than 60,000 healthcare and community service workers across Ontario. The union's members work in hospitals, homecare, nursing and retirement homes, and community services throughout the province. SEIU Healthcare has a strong track record of improving wages, benefits and working conditions for healthcare workers, supporting the training and development needs of its members, and strengthening standards in the management and delivery of patient and client care. www.seiuhealthcare.ca
SOURCE SEIU Healthcare
35th Anniversary of HIV Discovery on April 23
40 million globally live with HIV
1 million per year die of AIDS
By Peter Rosenberger
It has been 35 years since the historic discovery of HIV, the retrovirus believed to cause AIDS.
Following three long and scary years since first learning about a then-nameless but virtually always fatal illness, the world held its collective breath as HHS Secretary Margaret Heckler stood at the podium for a press conference on April 23, 1984. Secretary Heckler announced that Dr. Robert Gallo and his colleagues at the National Cancer Institute had discovered the cause of AIDS, a retrovirus labeled HTLV-III/LAV (human T-cell lymphotropic virus-type III/lymphadenopathy-associated virus), later named HIV. Secretary Heckler went on to express her hope of a cure within two years.
Those matter of fact words that were spoken to me still echoes decades later. A close friend faced an uncertain future as a hemophiliac in the mid-1980’s. When asked about his concern over the blood transfusions he regularly needed, his answer came with a sense of acceptance—but not one of defeat.
Sadly, within just a few years, he received blood tainted with HIV. Most everyone living with hemophilia at that time in my home state of South Carolina contracted the virus from that infected supply.
He was the second in our rural area to succumb to AIDS. Performing at his funeral, my wife and I chose a song he often sang during his difficult years. As she sang, she stood somewhat awkwardly on her new prosthetic leg. She eventually lost the other one in 1995. Both amputations, and her now 80 surgeries resulted from a car accident in 1983. To date, she’s received 48 blood transfusions. Virtually every surgery was met with great concern not only to her but many of the nurses treating her when any of her blood touched them. Despite the odds, she has avoided any HIV contaminated blood. Through it all, our journey of shared suffering knitted us to this man’s family.
Decades later, I still learn of the cruel treatment by neighbors, friends, and even family members, as my friend’s parents cared for their son with AIDS—condemned by many to bear their sorrow in isolation. While most disabilities and diseases isolate on some level, ostracizing tragically accompanied AIDS for vast numbers. As my own caregiving journey extends now beyond three decades, I can’t imagine doing so with the harsh exclusion this family faced.
Although reports are slowly surfacing about a possible cure for a disease which dominated headlines for years, many now are unfamiliar with the terror of AIDS. A new generation remains all but unaware of the nightmare, sorrow, shame, and the heartbreak endured by so many.
In his 2019 state of the union address, President Trump proclaimed an ambitious and important goal of ending this disease within ten years. One can’t help but wonder how that affects so many family members who quietly visit a grave, memorial site, or the quilt. Is their pain eased by such a lofty goal from the President? The loss and isolation felt by so many must still fill their eyes with hot tears.
A caregiver orbits someone living with a chronic impairment or disease. Sometimes, the presumed caregiver (spouse, partner, or family member) walks away. Such was the case for many traveling the dark path of AIDS. In their moment of greatest need, the disease not only took lives, but the stigma also severed the bonds of companionship. Many served as a caregiver for a friend with AIDS abandoned by family—although they themselves carried the disease. They soldiered on, even while watching their impending fate tragically displayed in the life of a dying friend. Others grieved alone when families circled their loved one while excluding a partner.
Embracing those who suffer is problematic when demanding to first know the cause. I learned that principle when grasping the hand of a patient in a prosthetic limb clinic we partner within Ghana. Her outstretched maimed hand bore the scars of leprosy. Admittingly doing so while gulping, I took that hand—while noticing scars running up her arm and her missing leg. Hugging her, I welcomed her into the clinic as she welcomed me into a new way of embracing the suffering.
AIDS is not cured. Maybe the President is correct, and we can eliminate this disease in ten years. But we don’t have to wait ten years to embrace those—and their caregivers—who live with HIV and AIDS.
To our collective shame, too many turned their backs on the sick and dying. While treatment has improved and AIDS doesn’t garner the headlines it once did, the residual scars of abandonment remain.
Caring for the suffering, regardless of the cause, remains one of our higher aspirations. Maybe the highest. Yet, only doing so to those with lifestyles sympathetic to one’s beliefs inhibits our own hearts to expand. Through many dark roads, I’ve seen the hands of those reaching to assist me in my heartache and loss. Although often serving as a poor steward of the grace shown to me, I’ve discovered the care one receives is best honored when extended to others.
With great zeal, let us eradicate AIDS in ten years or less. Yet, with that same zeal, let us collectively embrace the suffering, and those caring for them, regardless of the cause. Afterall, our paths are linked. Loving another human being means we will most likely one day be a caregiver. Living long enough ensures we will need one.
Toronto’s Architectural “Gems” Walking Tour for a Cure
(Kitchener, ON) April 18, 2019 – Join the Toronto Chapter of the Huntington Society of Canada for the Annual Wiswell Family Gems Walk. Every year, the group gathers in a different neighbourhood to explore the fascinating history that can be found within Toronto’s beautiful architecture. This year’s 90-minute walk will feature Toronto’s Towers and how they have changed over the last century. The walk will close with a social at the Elephant and Castle for participants to reminisce about the walk and meet other families affected by Huntington disease (HD). This event is the inspiration of a local Toronto resident, Jim Wiswell, a lover of city’s neighbourhoods who suffers from HD.
What? Annual Wiswell Family Gems Walk + Social
When? Sunday, April 28, 2019, Meet at 1:00 p.m., Walk at 2:00 p.m., Social at 4:00 p.m.
Where? Walk: Meet at David Pecaut Square, opposite the Royal Alexandra Theatre, 260 King St. West
Huntington disease (HD) is a debilitating brain disorder that is fatal and incurable. About one in every 7,000 Canadians has HD and approximately one in every 5,500 is at-risk of developing the disease. Many more are touched by HD whether as a caregiver, a family member, or a friend. Huntington disease is often described as having the symptoms of Alzheimer’s, Parkinson’s and ALS – simultaneously. As the disease progresses, a person with Huntington’s become less able to manage movements, recall events, make decisions and control emotions. The disease leads to incapacitation and, eventually, death.
The Huntington Society of Canada (HSC) is a respected leader in the worldwide effort to find a meaningful treatment for Huntington disease. HSC is the only Canadian health charity dedicated to providing help and hope for families dealing with Huntington disease across Canada.
The year was 1979. The Village People had just released ‘YMCA’ and Gloria Gaynor had a hit with ‘I Will Survive.’ Disco fashions and feathered hair were popular among men and women, and there was more emphasis than ever on physical appearance with the rise of exercise as a hobby.
GoodLife Fitness launched its first club in London, Ontario in 1979 just as fitness was going mainstream in a big way. More people were taking up bodybuilding thanks to the endorsement of Arnold Schwarzenegger. Treadmills moved from the doctor’s office to the gym as a way to incorporate recreational running into daily lives. The stage was set for Jane Fonda and Richard Simmons to get people stepping and kicking to the music.
Maureen ‘Mo’ Hagan, a licensed physiotherapist and vice president of program innovation with GoodLife Fitness, has been dedicated to group fitness since aerobics went mainstream in the early ‘80s. Hagan mastered the most popular aerobics workouts then adapted them with her own style and physio training to create classes for GoodLife Fitness clubs.
Although there have been fads over her nearly 40 years with the company, Hagan says certain types of fitness classes remain popular because they’re effective, entertaining and can be easily delivered by a variety of instructors, who are properly trained to teach group fitness. Here are some of Hagan’s favourite types of group fitness over four decades:
Aerobics: Aerobic exercise has fundamental elements that are still part of many group fitness workouts today – cardio (aerobic) exercise remains a great way to burn calories and improve heart health, the upbeat music and fun instructors make workouts more appealing and ‘express’ timeframe means it’s easier to fit a workout into your busy schedule.
Dance-inspired fitness – Jazzercise kicked off the dance fitness trend in 1984, combining great music and high tempo dance moves. In the ‘90s, Columbian dance instructor Beto Perez took dance-inspired workouts to a new level by combining Latin dance moves with great music and lots of opportunities for instructors to include their own personal touches. These variables made Zumba a huge hit. Today dance workouts feature the latest club moves and keep people moving to the beat while having fun.
Martial arts-inspired fitness – Billy Blanks brought martial arts to the forefront with Tae Bo in the 1990s. People loved getting active with action moves from their favourite kung-fu movies. Martial-arts added the entertainment value people crave to take their minds off how hard they’re working. Kickboxing and martial arts remain popular today as a way to build cardio and strength with extra attitude and a positive mindset.
Spinning – Cyclist Johnny Goldberg was the first to introduce spinning as a form of fitness in 1987. He designed the first spin bike and introduced a class that delivered extreme cardio in a fun, high energy environment. Spinning has since been adapted to focus more on overall conditioning high-intensity interval training. It still relies on high energy music and a lot of personality from its instructors to deliver the fun factor.
Yoga & Pilates – While yoga has been around forever, it only hit the mainstream in recent years as Baby Boomers looked for an effective workout that would tone and strengthen while minimizing injury. Both yoga and Pilates are now extremely popular with Boomers and Millennials alike who are looking to build strength, flexibility, and stamina while enjoying mindfulness and stress release.
Mo Hagan, and fitness experts in your area are available to talk more about the fads that failed, as well as the fundamental programs that have lasted four decades.
GoodLife group fitness instructors across Canada are available to do a high energy ‘dance evolution’ style demonstration of moves from fundamental group fitness movements since 1979 – from aerobics to Zumba, to martial arts and yoga/Pilates. We’ll provide the retro-music
Can cannabis use help with sleep apnea, weaken immune response and alter breathing tests?
The Lung Association - Ontario and Tetra Bio-Pharma research award recipients hope to help fill gaps in knowledge
TORONTO, April 16, 2019 /CNW/ - With the recent legalization of recreational cannabis in Canada, a major gap has been revealed, and that is a lack of scientific research on the health effects of its use – both on the recreational and medical side.
The research partnership between The Lung Association - Ontario and Tetra Bio-Pharma to better support patients and healthcare providers with evidence-based information about the impact of cannabis use has gotten off the ground with the announcement of the three research grant recipients. The winners were announced at The Lung Association – Ontario's Breathe! Bash held on March 28th.
The three new research investigations are:
Dr. Jeremy Hirota from McMaster University will be determining if smoking cannabis increases the risk of viral respiratory tract infections.
Dr. Tetyana Kendzerska from The Ottawa Hospital Research Institute, University of Ottawa will be filling the knowledge gap on the effects of recreational cannabis on obstructive sleep apnea, one of the most common disorders of sleep.
Dr. Nicholas Vozoris from St. Michael's Hospital, University of Toronto will be examining if smoking cannabis affects breathing tests, and if doctors should be using these tests when seeing patients with lung troubles who smoke cannabis.
These important research projects will ensure there is a larger evidence-base to pull from when educating the public and healthcare providers about the impact of cannabis use on lung health.
"Cannabis is a very polarizing topic, but as scientists we should approach things with data, with experiments to test hypotheses, and then based on the data make an informed decision," said Dr. Jeremy Hirota, Assistant Professor, McMaster University.
"Despite promising initial findings, there is a need for studies comparing the acute effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on respiratory disturbances during sleep and daytime alertness in people with obstructive sleep apnea in order to provide initial insights about potential mechanisms of action and to inform subsequent trials with longer treatment periods," said Dr. Tetyana Kendzerska, Associate Professor, The Ottawa Hospital Research Institute, University of Ottawa.
"While it is known that cannabis smoking can lead to respiratory symptoms and lung tissue damage in a similar manner as cigarette smoking can, many studies so far have curiously failed to show that smoking cannabis negatively affects lung function testing," said Dr. Nicholas Vozoris, Associate Scientist, St. Michael's Hospital, University of Toronto. "Further investigation is urgently needed to clarify if this is indeed the case, and if this is the case, then understanding why the difference between cigarettes and cannabis. I am grateful to The Lung Association for supporting this important area of respiratory research."
According to George Habib, President & CEO, The Lung Association Ontario, "The results of these projects will ensure that healthcare providers and the public have the evidence they need to better inform the decisions they make on behalf of their patients or themselves around the use of cannabis."
"We are delighted by the considerable interest and scope of novel submissions that were received from healthcare professionals for this research grant," said Dr. Guy Chamberland, CEO and CSO of Tetra Bio-Pharma. "Not only are we excited to partner with the Lung Association - Ontario on expanding the scientific data available on the medical use of cannabis, but these projects demonstrate the ingenuity of Canadian investigators in areas that have the potential to impact the lives of many individuals with lung-related health conditions. We can't wait to see what is discovered."
About The Lung Association – Ontario The Lung Association - Ontario is a not-for-profit organization dedicated to helping all Ontarians breathe. Our community of donors, patients, researchers, volunteers and professional staff work to ensure Ontarians have healthy lungs, bodies and clean air necessary to breathe. We achieve this by promoting healthy breathing, supporting those living with lung disease and finding future solutions. All of this is done with the goal of delivering a future of better breathing for all.
About Tetra Bio-Pharma Inc. Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-derived drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabinoid-derived molecules and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com
SOURCE Ontario Lung Association
Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada
BURLINGTON, ON, April 16, 2019 /CNW/ - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates Ltd. ("TFB") dated April 4, 2019 (the "Agreement") granting TFB preferred rights to distribute and sell RDT's QuickStrip™, an innovative, proprietary delivery technology for nutraceuticals to the Over The Counter Canadian retail market.
Under the terms of the Agreement, TFB will purchase, build inventory, market and distribute RDT's line of QuickStrip™ nutraceutical products across all Canadian retail outlets, including but not limited to, chain and independent pharmacies, mass merchants, health food stores, grocery and convenience stores.
RDT's proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral, fast-dissolving drug delivery system offering consumers an alternative to pills, capsules, drinks and injections. The QuickStrip™ nutraceutical product line delivers vitamin B12, caffeine and melatonin — penetrating the vitamin, energy and sleep consumer markets.
TFB is a long-standing privately owned importer and distributor of food, beverage and health care products, bringing a wealth of knowledge, experience and success launching new brands into the retail market.
"Our strategic relationship with TFB allows RDT to launch our QuickStrip™ brand of nutraceutical products in retail stores across Canada — offering consumers a novel way to take their vitamins and supplements. This Agreement will provide QuickStrip™ brand awareness and access to targeted locations and consumers in the rapidly growing nutraceutical market," said Mark Upsdell, CEO. "Our relationship with TFB further strengthens and positions QuickStrip™ for accelerated growth as an innovative global brand and delivery system to consumers with a focus on health and wellness."
"We are very excited to work with Rapid Dose Therapeutics in launching their brand in the Canadian retail marketplace," said Brian Riddell, Vice-president, Healthcare, TFB. "This new product brings innovation to the category with a quick and easy way to administer B12, Caffeine and Melatonin, something we haven't seen before. With a strong consumer awareness strategy and a strategic retail launch plan in place, we look forward to bringing this product to the Canadian consumer."
About Rapid Dose Therapeutics
Rapid Dose Therapeutics Corp. is a publicly-traded Canadian life sciences company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries. Within the cannabis sector, RDT provides a turn-key Managed Strip Service Program which enables RDT's QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT's service based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. Rapid Dose Therapeutics is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs — including humans, animals and plants.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws.
Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend", "will", "could", "are planned to", "are expected to" or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of equipment and products using the QuickStrip™ product delivery method and the generation of revenues from signed White Label Manufacturing Agreements, express, as at the date of this news release, the plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results and are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by RDT management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such forward-looking statements. Readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
World’s First 3D-printed Heart with Human Tissue
Hope for Millions of Americans with Heart disease
Each minute of every day, more than one person will die from a heart-related event. The American Heart Association reported that in 2019 more than 100,000 Americans were in need of a heart transplant, but only 3,244 were able to receive the transplant. The CDC states that 49% of Americans have at least 1 of the 3 main risk factors in developing heart disease. In cases of end-stage heart failure, the only option of potentially life-saving treatment is a heart transplant. Joining us in this discussion is Eddie Fatakhov, M.D. and author of the new book “Dr. Fat Off: simple Life-Long Weight-Loss Solutions.”
Q&A:
Why is it important to have this technology how many people are affected with heart disease?
Answer: According to the CDC, heart disease is the leading cause of death in the United States. The American Heart Association reported that in 2019 more than 100,000 Americans in need of a heart transplant, but only 3,244 were able to receive the transplant.
Heart transplants can save the lives of those with failing hearts. The Mayo Clinic reports that there are approximately 3,000 people in the United States waiting for heart transplants. Having this technology can help the suffering of people with End-Stage Heart Failure.
How is this different from other 3D transplant technologies?
Answer: This is the first that has built a full organ including human cells including vessels, matrix, chambers and ventricles so rejection will not occur. Other organs that have been printed successfully are much simpler, including bladders, ears, blood vessels, and windpipes.
Given we are 10 years away, how can we use this technology today to help people with heart disease?
Answer: This technology can be used sooner than 10 years as this technology can be used as a patch in damaged hearts versus full heart transplantation.
What can people do to prevent heart disease in the first place?
Answer: People need to modify their diet, increase their physical activity, and stop eating fast food. Making a few small changes to a person’s lifestyle can prevent some of the most dangerous diseases in the world.
Where do you see this technology being used in the future?
Answer: We can expect this to see be seen at every hospital across the nation where patients can come in for an office visit get a biopsy for his tissue and have his organ printed and surgery scheduled.
Where may we get a copy of your book “Dr. Fat Off: simple Life-Long Weight-Loss Solution” and the latest tips on dieting, healthy living and preventing heart disease.
Dr. Eddie Fatakhov, M.D. is a board-certified internal medicine physician, nutritionist, best-selling author, and wellness expert. Dr. Fatakhov is the author of “Dr. Fat Off: Simple Life-Long Weight-Loss Solutions,” “The Doctors’ Clinic-30 Program,” and contributing author to “Internal Medicine: Guide to Residency.” Dr. Fatakhov has been published in U.S. News & World Report and featured on CNN and syndicated radio shows.
In a new interview with CMRubinWorld, the renowned founder of Design for Change says her 4 step framework, “I Can,” is key to a desirable and sustainable future.
NEW YORK (PRWEB) APRIL 16, 2019
Feel, Imagine, Do, Share -- the FIDS Framework -- is the brainchild of Design for Change Founder Kiran Bir Sethi. Sethi, a teacher and principal at the Riverside Education Foundation in India, created the simple 4 step program for 8 - 13 year old children. It is the starting point for teaching youth their 5 Es: Empathy, Ethics, Excellence, Elevation and Evolution, with the key goal of nurturing more creative, empathetic and responsible citizens.
In a new interview with C.M. Rubin, founder of CMRubinWorld, Sethi discusses how the FIDS Framework was first launched and sent to 30,000 schools across India. The program positions children as “our today” and aims to provide them with “all the ingredients to make the world a better place.”
Today, Design for Change is used in over 65 countries by approximately 60,000 schools. “The framework has allowed so many schools and teachers to get excited that they can,” says Sethi. “When children are listened to and given that respect, we see them take ownership for the change and in that we see them design with communities rather than for.”
Kiran Bir Sethi is a Graphic Designer, former Teacher and Principal, an Education Reformer and the Founder of Design for Change. Her globally recognized award-winning program is currently used in 60,000 schools in 65 countries.
CMRubinWorld’s award-winning series, The Global Search for Education, brings together distinguished thought leaders in education and innovation from around the world to explore the key learning issues faced by most nations. The series has become a highly visible platform for global discourse on 21st century learning, offering a diverse range of innovative ideas which are presented by the series founder, C. M. Rubin, together with the world’s leading thinkers.
Eating KETO? Conquer Sugar Cravings Without Compromising Taste
Safe for most diets, all natural jel and pudding desserts are simple to make, more fun to share
SAN DIEGO, California – (April 16, 2019):Simply Delish All Natural Jel Desserts and puddings are the ideal sweet treat for KETO diet fans. Originating in South Africa and now a beloved U.S. household brand since 2002, Simply Delish is committed to creating plant-based, Non-GMO Verified, sugar-free, lactose-free and guilt-free desserts that capture the flavors of nature making it the perfect treat for adults and kids alike.
Crafted without preservatives or artificial colors and naturally low in carbohydrates, Simply Delish is the perfect cheat-free treat for KETO and vegan dieters and those with food sensitivities. The gluten and gelatin-free Simply Delish natural Jel desserts have zero carbs, only 5 calories per serving, and features fresh summertime flavors to suit every craving: strawberry, raspberry, orange and peach, and their non-dairy Pudding Desserts in creamy vanilla, decadent chocolate, and sweet strawberry. What makes these puddings so unique is they can be prepared with Coconut Milk, Almond Milk, Soy Milk or any plant-based milk you like.
Every box of Simply Delish is simple to make and even more, fun to share. Each delectable flavor is approved for most diets, including Kosher, Halaal and gluten-free. Make every meal a celebration or choose Simply Delish as the ideal, worry-free addition to any summer barbecue or graduation party.
Curb sugar cravings and keep on-track with KETO by adding Simply Delish All Natural Jel Desserts and non-dairy Pudding to the grocery list. Visit SimplyDelish.netto shop every flavor and get free shipping with a purchase of six or more.
About Simply Delish:
Simply Delish’s vegan Jel desserts and non-dairy Puddings are crafted without added sugar, GMOs, preservatives or artificial colors and naturally low in carbohydrates, Simply Delish is the perfect treat for adults and kids alike. Their Jels have zero carbs and only have 5 calories per serving which cater to a wide variety of individuals, from Keto lifestyle consumers, Fitness enthusiasts, Diabetes to someone looking to make Vegan Jel Shots for their next get together. Visit www.simplydelish.net to learn more about the Simply Delish range of Jels and Puddings. You can also find them online through their website as well as Amazon.com and at Whole Foods, Jewel supermarkets or one of over 1,000 independent natural food stores nationwide.
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
